Behar S, Tanne D, Abinader E, Agmon J, Barzilai J, Friedman Y, Kaplinsky E, Kauli N, Kishon Y, Palant A
Neufield Cardiac Research Institute, Tel Hashomer, Israel.
Am J Med. 1991 Jul;91(1):45-50. doi: 10.1016/0002-9343(91)90072-6.
The purpose of this study was to report the incidence, the antecedents, and the clinical significance of clinically recognized cerebrovascular accidents or transient ischemic attacks (CVA-TIA) complicating acute myocardial infarction.
During 1981 to 1983, a secondary prevention study with nifedipine (SPRINT) was conducted in 14 hospitals in Israel among 2,276 survivors of acute myocardial infarction. During the study, demographic, historical, and medical data were collected on special forms for all patients with diagnosed acute myocardial infarction in 13 of these 14 hospitals (the SPRINT registry, n = 5,839). Mortality follow-up was completed for 99% of hospital survivors for a mean follow-up of 5.5 years (range: 4.5 to 7 years).
The incidence of CVA-TIA was 0.9% (54 of 5,839). The latter rate increased significantly only with age, from 0.4% among patients up to 59 years old to 1.6% among those aged greater than or equal to 70 years. Multivariate analysis identified age, congestive heart failure, and history of stroke as predictors of CVA-TIA during the acute phase of myocardial infarction. Patients with CVA-TIA exhibited a complicated hospital course, with a 15-day mortality rate of 41%. Subsequent mortality rates in survivors at 1 and 5 years were 34% and 59%, respectively. Rates at the same time points in patients without CVA-TIA were 16%, 11%, and 29% (p less than 0.01). In a multivariate analysis that included age, gender, congestive heart failure, history of previous myocardial infarction, and hypertension, CVA-TIA was independently associated with increased 15-day mortality (covariate-adjusted odds ratio [OR] = 2.62; 90% confidence interval [CI], 1.59 to 4.32), as well as subsequent 1-year (OR = 3.29; 90% CI, 1.70 to 6.36) and long-term (mean follow-up = 5.5 years) mortality (OR = 2.46; 90% CI, 1.30 to 4.69).
In this large cohort of consecutive patients with myocardial infarction, CVA-TIA was a relatively infrequent complication of acute myocardial infarction. Factors independently favoring the occurrence of CVA-TIA were old age, previous CVA, and congestive heart failure. CVA-TIA occurring during acute myocardial infarction independently increased the risk of early death threefold as well as the risk of long-term mortality in early-phase survivors. (2.5-fold).
本研究旨在报告并发急性心肌梗死的临床确诊脑血管意外或短暂性脑缺血发作(CVA-TIA)的发生率、前驱因素及临床意义。
1981年至1983年期间,在以色列的14家医院对2276例急性心肌梗死幸存者进行了一项硝苯地平二级预防研究(SPRINT)。研究期间,在这14家医院中的13家(SPRINT登记处,n = 5839),采用特殊表格收集了所有确诊急性心肌梗死患者的人口统计学、病史及医学数据。对99%的医院幸存者完成了平均5.5年(范围:4.5至7年)的死亡率随访。
CVA-TIA的发生率为0.9%(5839例中的54例)。该发生率仅随年龄显著增加,从59岁及以下患者中的0.4%增至70岁及以上患者中的1.6%。多因素分析确定年龄、充血性心力衰竭及中风病史为心肌梗死急性期CVA-TIA的预测因素。发生CVA-TIA的患者住院过程复杂,15天死亡率为41%。幸存者1年和5年的后续死亡率分别为34%和59%。无CVA-TIA患者在相同时间点的死亡率分别为16%、11%和29%(p < 0.01)。在一项纳入年龄、性别、充血性心力衰竭、既往心肌梗死病史及高血压的多因素分析中,CVA-TIA与15天死亡率增加独立相关(协变量调整比值比[OR] = 2.62;90%置信区间[CI],1.59至4.32),以及后续1年(OR = 3.29;90% CI,1.70至6.36)和长期(平均随访 = 5.5年)死亡率(OR = 2.46;90% CI,1.30至4.69)。
在这一大型连续性心肌梗死患者队列中,CVA-TIA是急性心肌梗死相对少见的并发症。独立促进CVA-TIA发生的因素为老年、既往CVA及充血性心力衰竭。急性心肌梗死期间发生的CVA-TIA使早期死亡风险独立增加三倍,以及使早期幸存者的长期死亡风险增加(2.5倍)。